◀ Back to RNF19A
PLA2G4A — RNF19A
Text-mined interactions from Literome
Wen et al., J Cell Biochem 2000
:
On the other hand, rottlerin ( the selective PKCdelta inhibitor ), SB 203580 ( the selective
p38 MAPK inhibitor ), and wortmannin ( the PI 3-kinase inhibitor ) can
affect neither
cPLA(2) nor ERK phosphorylation
Awasthi et al., Am J Physiol Lung Cell Mol Physiol 2001
:
We hypothesize that CT activity is inhibited by the lysoPC generated as a consequence of the
activation of
cPLA2 by protein kinase C-alpha and
p38 mitogen activated protein kinase
Kalyankrishna et al., J Pharmacol Exp Ther 2003
:
NE-induced
p38 MAPK activation was found to be mediated through the stimulation of alpha-1 and alpha-2 adrenergic receptors, was dependent on extracellular Ca ( 2+ ), and was
attenuated by an inhibitor of
cPLA(2) ( pyrrolidine-1 )
Kang et al., Int Arch Allergy Immunol 2008
(Anaphylaxis) :
Either
p38 or an ERK inhibitor significantly
attenuated not only
cPLA(2) phosphorylation and activity, but also the late-phase anaphylaxis
Vignola et al., J Biol Chem 2010
:
Furthermore, the MAPK
p38 was primarily
responsible for
cPLA(2) activation in Chlamydia infected cells and IRG expression